| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Physiology and Biophysics, The University of Iowa College of Medicine, Iowa City, Iowa 52246
Address all correspondence and requests for reprints to: Dr. Deborah L. Segaloff, Department of Physiology, The University of Iowa College of Medicine, Iowa City, Iowa 52242. E-mail: deborah-segaloff{at}uiowa.edu
The lutropin/choriogonadotropin receptor (LHR) and follitropin receptor (FSHR) are members of the superfamily of G protein-coupled receptors. The carboxyl half of each receptor is composed of the classical seven membrane spanning regions connected by intracellular and extracellular loops. In addition, each receptor contains a large extracellular domain. Despite the complexity of the structure of G protein-coupled receptors, little is known about how these receptors assume their correct conformations during biosynthesis. Although the role of chaperone proteins in the folding of other proteins has been well documented, their role in the folding of G protein-coupled receptors has been an enigma. To better understand the folding of the LH and FSH receptors, we examined their association with the general chaperone proteins calnexin, binding protein (BiP), and the 94-kDa glucose-regulated protein (GRP94). Clonal 293 cell lines expressing comparably high levels of each receptor were solubilized, and the extracts were incubated with the appropriate antibody bound to Protein A-sepharose beads. Experiments were performed using two approaches: 1) coimmunoprecipitation of receptor/chaperone complexes with one of the antireceptor antibodies, then SDS-PAGE and Western blotting using either anticalnexin or anti-KDEL (which recognizes BiP and GRP94) antibodies; or 2) coimmunoprecipitation of receptor/chaperone complexes with anticalnexin or anti-KDEL, then Western blotting with one of the antireceptor antibodies. Using these protocols, we found that the immature forms of both the rLHR and rFSHR are associated with calnexin, but little or no association was observed for either receptor with BiP or GRP94. These experiments show that the precursor forms of the wild-type LHR and FSHR can associate with calnexin, raising the possibility that this chaperone protein may facilitate in the folding of the gonadotropin receptors.
This article has been cited by other articles:
 |
|
 |
|
  P. M. Conn, A. Ulloa-Aguirre, J. Ito, and J. A. Janovick G Protein-Coupled Receptor Trafficking in Health and Disease: Lessons Learned to Prepare for Therapeutic Mutant Rescue in Vivo Pharmacol. Rev., September 1, 2007; 59(3): 225 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Free, L. A. Hazelwood, D. M. Cabrera, H. N. Spalding, Y. Namkung, M. L. Rankin, and D. R. Sibley D1 and D2 Dopamine Receptor Expression Is Regulated by Direct Interaction with the Chaperone Protein Calnexin J. Biol. Chem., July 20, 2007; 282(29): 21285 - 21300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhu, Y. Imanishi, S. Filipek, A. Alekseev, B. Jastrzebska, W. Sun, D. A. Saperstein, and K. Palczewski Autosomal Recessive Retinitis Pigmentosa and E150K Mutation in the Opsin Gene J. Biol. Chem., August 4, 2006; 281(31): 22289 - 22298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Hawtin Pharmacological Chaperone Activity of SR49059 to Functionally Recover Misfolded Mutations of the Vasopressin V1a Receptor J. Biol. Chem., May 26, 2006; 281(21): 14604 - 14614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Robert, C. Auzan, M. A. Ventura, and E. Clauser Mechanisms of Cell-surface Rerouting of an Endoplasmic Reticulum-retained Mutant of the Vasopressin V1b/V3 Receptor by a Pharmacological Chaperone J. Biol. Chem., December 23, 2005; 280(51): 42198 - 42206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Frenzel, K. Krohn, M. Eszlinger, A. Tonjes, and R. Paschke Sialylation of Human Thyrotropin Receptor Improves and Prolongs Its Cell-Surface Expression Mol. Pharmacol., October 1, 2005; 68(4): 1106 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ascoli Learning New Tricks from an Old Dog: The Processing of the Intracellular Precursor of the Luteinizing Hormone Receptor (LHR) into the Mature Cell-Surface LHR Is a Regulated Process Endocrinology, August 1, 2005; 146(8): 3221 - 3223. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yamashita, K. Nakamura, Y. Omori, K. Tsunekawa, M. Murakami, and T. Minegishi Association of Human Follitropin (FSH) Receptor with Splicing Variant of Human Lutropin/Choriogonadotropin Receptor Negatively Controls the Expression of Human FSH Receptor Mol. Endocrinol., August 1, 2005; 19(8): 2099 - 2111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mizrachi and D. L. Segaloff Intracellularly Located Misfolded Glycoprotein Hormone Receptors Associate with Different Chaperone Proteins than Their Cognate Wild-Type Receptors Mol. Endocrinol., July 1, 2004; 18(7): 1768 - 1777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nakamura, S. Yamashita, Y. Omori, and T. Minegishi A Splice Variant of the Human Luteinizing Hormone (LH) Receptor Modulates the Expression of Wild-Type Human LH Receptor Mol. Endocrinol., June 1, 2004; 18(6): 1461 - 1470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ulloa-Aguirre, J. A. Janovick, A. Leanos-Miranda, and P. M. Conn Misrouted cell surface GnRH receptors as a disease aetiology for congenital isolated hypogonadotrophic hypogonadism Hum. Reprod. Update, March 1, 2004; 10(2): 177 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Chaipatikul, L. J. Erickson-Herbrandson, H. H. Loh, and P.-Y. Law Rescuing the Traffic-Deficient Mutants of Rat {micro}-Opioid Receptors with Hydrophobic Ligands Mol. Pharmacol., July 1, 2003; 64(1): 32 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ascoli, F. Fanelli, and D. L. Segaloff The Lutropin/Choriogonadotropin Receptor, A 2002 Perspective Endocr. Rev., April 1, 2002; 23(2): 141 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Nagayama, E. Nishihara, H. Namba, S. Yamashita, and M. Niwa Identification of the Sites of Asparagine-Linked Glycosylation on the Human Thyrotropin Receptor and Studies on Their Role in Receptor Function and Expression J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 404 - 409. [Abstract] [Full Text]
|
|
|
|
|
|
L. Fayadat, S. Siffroi-Fernandez, J. Lanet, and J.-L. Franc Calnexin and Calreticulin Binding to Human Thyroperoxidase Is Required for Its First Folding Step(s) But Is Not Sufficient to Promote Efficient Cell Surface Expression Endocrinology, March 1, 2000; 141(3): 959 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Touraine, I. Beau, A. Gougeon, G. Meduri, A. Desroches, C. Pichard, M. Detoeuf, B. Paniel, M. Prieur, J-R Zorn, et al. New Natural Inactivating Mutations of the Follicle-Stimulating Hormone Receptor: Correlations between Receptor Function and Phenotype Mol. Endocrinol., November 1, 1999; 13(11): 1844 - 1854. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
